Medical News

RSS

QPID Health included in 'Cool Vendors' for Healthcare Providers report

QPID Health, a leader in clinical reasoning software, today announced it has been included in the "Cool Vendors" for Healthcare Providers report published by Gartner, Inc on April 3, 2015. QPID's innovative solutions help hospitals and medical groups optimize their investments in the information held within electronic health records to help improve patient outcomes and increase clinical satisfaction.

27 Apr 2015

Molecular Health granted European patent for novel Erythropoietin receptor

Molecular Health announced today it has been granted a patent in Europe entitled "Tissue Protective Erythropoietin Receptor". This latest patent supports Molecular Health's discovery that EPHB4 is a novel receptor for Erythropoietin (EPO), where EPHB4 binds to EPO and promotes tumor growth.

27 Apr 2015

Check-Cap announces Notice of Allowance from USPTO for endoscopy capsule technology

Check-Cap Ltd., a clinical stage medical diagnostics company engaged in the development of a preparation-free ingestible imaging capsule that utilizes low-dose X-rays for the screening for colorectal cancer, today announced receipt of a Notice of Allowance from the United States Patent and Trademark Office for patent application U.S. 13/825,018 entitled, "Estimation of Distances and Size of Lesions in the Colon with an Imaging Capsule."

27 Apr 2015

NanoViricides' anti-viral drug candidates show promise in lethal animal model of dermal herpes infection

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, discusses the significance of the strong effectiveness demonstrated by its anti-viral drug candidates in a lethal animal model of dermal herpes infection.

27 Apr 2015

TAXIS Pharmaceuticals' TXA709 compound shows promise in combating antibiotic resistance

TAXIS Pharmaceuticals, a drug-discovery company focused on developing a new class of antibiotic agents to treat life-threatening, multidrug-resistant bacterial infections, today announced the presentation of data demonstrating the promise of its lead clinical candidate, TXA709, in combating antibiotic resistance.

27 Apr 2015

Resverlogix, Hepalink announce equity investment and license agreement for RVX-208

Resverlogix Corp. today announced that it has entered into a Framework Agreement which sets forth the principal business terms for an equity investment and a license of RVX-208, for all indications, to Shenzhen Hepalink Pharmaceutical Co., Ltd. for China, Hong Kong, Taiwan and Macau (the "Territories").

27 Apr 2015

Preclinical data from Synthetic Biologics' SYN-005 for Pertussis treatment presented at ECCMID 2015

Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, announced that preclinical data from its novel SYN-005 program for the treatment of Pertussis were presented in two posters at ECCMID 2015 (European Congress of Clinical Microbiology and Infectious Diseases), on April 25, 2015, in Copenhagen, Denmark.

27 Apr 2015

Neuronetics completes Series F Financing Round

Neuronetics, Inc., the established market leader in transcranial magnetic stimulation (TMS) technology, announced today the completion of its Series F Financing Round, which included investment from GE Ventures, as well as its original investor base totaling $34.3 million.

27 Apr 2015

Merrimack completes submission of MM-398 NDA for treatment of post-gemcitabine metastatic pancreatic cancer

Merrimack Pharmaceuticals, Inc. and Baxter International Inc. today jointly announced that Merrimack has completed the rolling submission of the New Drug Application (NDA) for MM-398 (irinotecan liposome injection), also known as "nal-IRI," to the U.S. Food and Drug Administration.

From Baxter International Inc. 27 Apr 2015

Grammy Award-winning poet recognized with Top Blacks in Healthcare award

As a Grammy Award-winning poet, J. Ivy is celebrated throughout pop culture for his performance poetry, motivational speaking and hip-hop collaborations. Currently, with his new book "Dear Father: Breaking the Cycle of Pain," he will be recognized by BlackDoctor.org with a Top Blacks in Healthcare award at their gala on April 30, 2015.

27 Apr 2015

Can-Fite announces favorable data from further analysis of CF101 Phase II/III study in patients with psoriasis

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today favorable data from further analysis of its Phase II/III double-blind, placebo-controlled study designed to test the efficacy of CF101 in patients with moderate-to-severe plaque psoriasis.

27 Apr 2015

aTyr's Resolaris granted FDA Orphan Drug Designation for treatment of FSHD

aTyr Pharma, a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases, announced today that Resolaris has been granted Orphan Drug Designation by the U.S. Food and Drug Administration for the treatment of facioscapulohumeral muscular dystrophy (FSHD).

27 Apr 2015

American Securities signs agreement to acquire Royal Adhesives and Sealants

American Securities LLC and Arsenal Capital Partners today announced that American Securities has partnered with management and signed a definitive agreement to acquire Royal Adhesives and Sealants, LLC, a leading producer of proprietary, high-performance adhesives and sealants, from Arsenal Capital Partners.

27 Apr 2015

Many transgender people refrain from going to health care providers to avoid social stigma

Discussing your sexual history with a doctor, or anyone for that matter, can be an uncomfortable experience. But for many transgender people, the conversation never takes place because they aren't seeking health care, according to Adrian Juarez, PhD, a public health nurse and assistant professor in the University at Buffalo School of Nursing.

27 Apr 2015

New report on digital and computed radiography market in Thailand, Indonesia and Malaysia

With recent developments in Asia-Pacific healthcare delivery as well as the growing emphasis on reduced radiation, seamless workflow and safety measures, innovations in the digital and computed radiography market in Thailand, Indonesia and Malaysia (TIM) are inevitable.

27 Apr 2015

Haemonetics' revenue for fourth quarter fiscal 2015 down 6%

Haemonetics Corporation today reported revenue for the fourth quarter fiscal 2015 of $226.5 million, down 6%. Excluding currency impact, revenue was down 4% in the quarter. The Company reported a fourth quarter GAAP net loss of $2.9 million or $0.06 per share.

27 Apr 2015

Winners of Qatar University Scientists 2015 Scopus Awards announced

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and Qatar University Research Office have announced the winners of the Qatar University Scientists 2015 Scopus Awards.

27 Apr 2015

TWi signs Settlement Agreement with Takeda on patent litigation related to generic Dexilant

TWi Pharmaceuticals, Inc. today announced that it has entered into a Settlement Agreement with Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc. (individually and collectively, "Takeda") to settle and dismiss all outstanding patent litigation related to TWi's generic dexlansoprazole delayed release capsules for oral administration in 30 mg and 60 mg dosage strengths.

27 Apr 2015

OncoGenex terminates agreement with Teva, regains rights to custirsen

OncoGenex Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, OncoGenex Technologies Inc., executed a termination agreement with Teva Pharmaceuticals Ltd. under which OncoGenex will regain rights to custirsen, an investigational compound currently in Phase 3 clinical development as a treatment for prostate and lung cancers.

27 Apr 2015

Scholars from leading U.S. medical schools issue updated recommendations on medical ethics training

The American health care landscape has changed significantly in the three decades since the landmark "DeCamp Report" first argued that ethics training should be required for all medical students, yet the fundamental importance of professionalism and ethical practice has only solidified.

27 Apr 2015

Medical News

QPID Health included in 'Cool Vendors' for Healthcare Providers report

Molecular Health granted European patent for novel Erythropoietin receptor

Check-Cap announces Notice of Allowance from USPTO for endoscopy capsule technology

NanoViricides' anti-viral drug candidates show promise in lethal animal model of dermal herpes infection

TAXIS Pharmaceuticals' TXA709 compound shows promise in combating antibiotic resistance

Resverlogix, Hepalink announce equity investment and license agreement for RVX-208

Preclinical data from Synthetic Biologics' SYN-005 for Pertussis treatment presented at ECCMID 2015

Neuronetics completes Series F Financing Round

Merrimack completes submission of MM-398 NDA for treatment of post-gemcitabine metastatic pancreatic cancer

Grammy Award-winning poet recognized with Top Blacks in Healthcare award

Can-Fite announces favorable data from further analysis of CF101 Phase II/III study in patients with psoriasis

aTyr's Resolaris granted FDA Orphan Drug Designation for treatment of FSHD

American Securities signs agreement to acquire Royal Adhesives and Sealants

Many transgender people refrain from going to health care providers to avoid social stigma

New report on digital and computed radiography market in Thailand, Indonesia and Malaysia

Haemonetics' revenue for fourth quarter fiscal 2015 down 6%

Winners of Qatar University Scientists 2015 Scopus Awards announced

TWi signs Settlement Agreement with Takeda on patent litigation related to generic Dexilant

OncoGenex terminates agreement with Teva, regains rights to custirsen

Scholars from leading U.S. medical schools issue updated recommendations on medical ethics training

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News